The test surveys an individual’s immune responsiveness to Sars-Cov-2 (COVID-19) virus, namely the nucleocapsid and spike proteins. The spike is the main protein used in COVID-19 vaccines. The SCOV™ ANTIBODIES profiles can simultaneously quantify the specificity and antibody response to this protein and may be a useful tool in making immunity assessments to COVID-19.  The assay is 100-1000 fold more sensitivity than similar assays presently on the market.